2014 annual financial data

Supernus Pharmaceuticals, Inc. 2014 Operating margin

Supernus Pharmaceuticals, Inc. 2014 operating margin with verified reported val…

Direct answer

Operating margin was 19.85%.

Operating income was 24,230,000 USD and net income was 19,871,000 USD.
Operating cash flow was 7,733,000 USD.

Get free Supernus Pharmaceuticals, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
122,045,000 USD
Operating income
24,230,000 USD
Net income
19,871,000 USD
Operating cash flow
7,733,000 USD